Theranos Criminal Investigation And Prosecution
Background: The Theranos Scandal
Theranos was a health technology startup founded by Elizabeth Holmes that claimed to have developed revolutionary blood-testing technology requiring only tiny amounts of blood. However, investigations revealed the technology was unreliable and that Theranos misled investors, regulators, and patients about its capabilities and performance. The scandal led to criminal prosecutions alleging fraud.
1. United States v. Elizabeth Holmes
Facts
Elizabeth Holmes, Theranos founder and CEO, was charged with criminal fraud for misleading investors and patients about the capabilities of the company’s blood-testing technology. Prosecutors alleged she knowingly made false statements about the accuracy, reliability, and regulatory status of the tests and the business prospects of Theranos.
Charges / Legal Basis
Wire fraud (fraudulent schemes using electronic communications to deceive investors and customers)
Conspiracy to commit wire fraud
Legal Issues & Evidence
Whether Holmes intentionally deceived investors about the technology’s capabilities and business performance.
Evidence included internal emails, presentations, statements to investors, and testimony from former employees.
Prosecution argued Holmes was aware of critical test failures but concealed them.
Defense argued Holmes believed in the technology and did not intentionally defraud.
Outcome
Holmes was found guilty on multiple counts of wire fraud and conspiracy.
Sentenced to a lengthy prison term (over 11 years).
The verdict reinforced that corporate leaders can be held criminally responsible for misleading investors.
Significance
Landmark prosecution highlighting accountability of tech startup founders.
Set precedent for fraud charges in high-profile Silicon Valley companies.
Raised awareness about the importance of due diligence by investors.
2. United States v. Ramesh "Sunny" Balwani
Facts
Sunny Balwani, former COO and President of Theranos and Elizabeth Holmes’s romantic partner, was separately charged with fraud for his role in the company’s operations and alleged deceptive practices.
Charges / Legal Basis
Wire fraud (against investors and patients)
Conspiracy to commit wire fraud
Legal Issues & Evidence
Balwani allegedly was deeply involved in day-to-day operations and aware of the technology’s shortcomings.
Prosecution presented emails, internal reports, and witness testimony showing active participation in the deception.
Defense argued lack of intent to defraud and denial of knowledge of falsehoods.
Outcome
Balwani was convicted on multiple counts of wire fraud and conspiracy.
Sentenced to over a decade in prison.
Significance
Demonstrated that senior executives, not just CEOs, can be prosecuted for corporate fraud.
Underscored the importance of executive accountability in biotech startups.
3. Civil Enforcement Action by the SEC against Elizabeth Holmes and Sunny Balwani
Facts
In parallel with criminal proceedings, the Securities and Exchange Commission (SEC) filed civil charges against Holmes and Balwani for raising more than $700 million from investors through an elaborate, years-long fraud.
Charges / Legal Basis
Civil charges for securities fraud (misleading investors, false statements in private funding rounds).
Legal Issues & Evidence
Whether Holmes and Balwani knowingly misrepresented material facts about the technology and business.
SEC cited investor presentations, emails, and whistleblower evidence.
Settlement discussions and admissions of wrongdoing played a role.
Outcome
Holmes agreed to settle with the SEC, paying a fine, relinquishing voting control, and barring herself from serving as an officer or director of a public company for 10 years.
Balwani settled separately with similar terms.
Significance
Civil actions complemented criminal prosecutions, emphasizing investor protection.
Highlighted the SEC’s role in policing startup fraud beyond the criminal system.
4. Whistleblower Lawsuits and Related Civil Cases
Facts
Theranos employees and investors filed multiple whistleblower suits and civil claims related to alleged fraudulent business practices, unsafe testing procedures, and shareholder losses.
Charges / Legal Basis
Claims included securities fraud, breach of fiduciary duty, and whistleblower retaliation.
Some whistleblowers provided key evidence used in the criminal investigations.
Legal Issues & Evidence
Focused on internal company practices, retaliation against employees who raised concerns, and misleading public statements.
Evidence included internal emails, lab results, and deposition testimony.
Outcome
Several lawsuits were settled confidentially.
Some whistleblower claims were instrumental in triggering regulatory investigations and federal criminal probes.
Significance
Showed the role of internal dissent and whistleblowers in exposing corporate fraud.
Reinforced protections for employees who report misconduct.
5. Regulatory Actions by CMS and FDA
Facts
The Centers for Medicare & Medicaid Services (CMS) revoked Theranos’s lab license in 2016 after inspections revealed serious deficiencies. The Food and Drug Administration (FDA) also scrutinized Theranos’s blood-testing devices and found significant issues.
Charges / Legal Basis
Administrative sanctions for violations of health and safety regulations.
Regulatory actions based on unsafe testing and failure to comply with medical device standards.
Legal Issues & Evidence
Whether Theranos’s devices met regulatory standards for safety and effectiveness.
Evidence from lab inspections, audits, and device testing.
Outcome
Theranos was forced to cease operations of its labs and devices.
These regulatory actions formed part of the public record used in criminal prosecutions.
Significance
Highlighted the importance of regulatory compliance in medical technology.
Provided critical evidence supporting fraud allegations.
Summary of Legal and Social Impact
The Theranos prosecutions are among the most high-profile cases showing criminal accountability for fraudulent biotech startups.
They highlight how misleading claims about technology and business can lead to serious criminal and civil consequences.
The cases reinforce the role of whistleblowers, regulatory oversight, and investor vigilance in preventing corporate fraud.
These prosecutions set a precedent that Silicon Valley’s “move fast and break things” culture has legal limits, especially in health-related fields.
RELATED Blog
0 comments